The University of Chicago Header Logo

Binh Phan

Concepts (167)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carotid Artery Diseases
7
2020
100
1.960
Why?
Dyslipidemias
4
2017
107
1.680
Why?
Hypolipidemic Agents
6
2018
99
1.520
Why?
Lipids
4
2014
276
1.490
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
380
1.340
Why?
Atherosclerosis
5
2016
264
1.030
Why?
Coronary Artery Disease
4
2021
373
0.980
Why?
Carotid Arteries
4
2018
135
0.980
Why?
Carotid Intima-Media Thickness
3
2020
39
0.770
Why?
HIV Infections
2
2020
852
0.670
Why?
Plaque, Atherosclerotic
3
2018
60
0.660
Why?
Cause of Death
1
2020
270
0.630
Why?
Heart Sounds
1
2017
1
0.570
Why?
American Heart Association
1
2017
95
0.550
Why?
Primary Prevention
1
2017
82
0.540
Why?
Cyclin D1
1
2016
84
0.520
Why?
Myocardial Contraction
1
2017
252
0.510
Why?
Pericardium
1
2016
70
0.500
Why?
Genes, Tumor Suppressor
1
2016
154
0.500
Why?
Guideline Adherence
1
2017
232
0.500
Why?
Foramen Ovale, Patent
1
2015
19
0.490
Why?
Anticholesteremic Agents
2
2016
141
0.490
Why?
Carotid Stenosis
2
2012
117
0.440
Why?
Gene Expression Regulation, Neoplastic
2
2016
1286
0.440
Why?
Cardiovascular Diseases
3
2015
726
0.440
Why?
Magnetic Resonance Imaging
4
2012
3486
0.430
Why?
Adipose Tissue
1
2016
263
0.430
Why?
Azetidines
2
2016
37
0.430
Why?
Triple Negative Breast Neoplasms
1
2016
176
0.430
Why?
Thrombosis
2
2015
312
0.420
Why?
Heart Diseases
1
2015
306
0.410
Why?
Coronary Stenosis
1
2012
39
0.400
Why?
Jejunum
1
2012
80
0.400
Why?
Intestinal Absorption
1
2012
125
0.390
Why?
Practice Patterns, Physicians'
1
2017
604
0.390
Why?
Heart Ventricles
1
2017
792
0.390
Why?
Hypertension
1
2017
746
0.370
Why?
MicroRNAs
1
2016
561
0.370
Why?
Cholesterol, HDL
4
2017
171
0.360
Why?
Disease Progression
4
2020
1486
0.350
Why?
Practice Guidelines as Topic
1
2017
1056
0.340
Why?
Cholesterol, LDL
6
2018
228
0.310
Why?
Blood Glucose
1
2012
849
0.310
Why?
Middle Aged
14
2020
26347
0.290
Why?
Chagas Cardiomyopathy
1
2006
4
0.270
Why?
Trypanosoma cruzi
1
2006
8
0.270
Why?
Lipoproteins, HDL
1
2006
97
0.260
Why?
Humans
24
2021
90640
0.260
Why?
Male
15
2020
42967
0.230
Why?
Niacin
4
2016
37
0.220
Why?
Risk Factors
4
2020
5583
0.220
Why?
Treatment Outcome
6
2018
8379
0.210
Why?
Magnetic Resonance Angiography
2
2018
275
0.200
Why?
Chi-Square Distribution
2
2017
360
0.200
Why?
Follow-Up Studies
4
2020
3698
0.190
Why?
Biomarkers
4
2018
1800
0.190
Why?
Incidence
3
2015
1594
0.180
Why?
Heart Transplantation
1
2006
744
0.180
Why?
Time Factors
4
2018
5366
0.170
Why?
Cell Proliferation
2
2016
1695
0.170
Why?
Coronary Angiography
2
2012
246
0.150
Why?
Female
11
2020
46894
0.150
Why?
Lipoprotein(a)
1
2018
30
0.150
Why?
Proportional Hazards Models
2
2017
841
0.150
Why?
Compliance
1
2017
21
0.140
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
888
0.140
Why?
Asymptomatic Diseases
1
2017
45
0.140
Why?
Chest Pain
1
2017
42
0.140
Why?
Heart Failure
1
2006
1270
0.130
Why?
Microphthalmia-Associated Transcription Factor
1
2016
14
0.130
Why?
Antigens, Nuclear
1
2016
25
0.130
Why?
Melanocytes
1
2016
57
0.130
Why?
Linear Models
1
2017
427
0.130
Why?
3' Untranslated Regions
1
2016
96
0.130
Why?
Proprotein Convertases
1
2015
26
0.130
Why?
Immunoblotting
1
2016
272
0.130
Why?
Adult
8
2018
26953
0.120
Why?
Antiphospholipid Syndrome
1
2015
21
0.120
Why?
Multivariate Analysis
1
2017
982
0.120
Why?
Clinical Trials as Topic
3
2016
1142
0.120
Why?
Electronic Nicotine Delivery Systems
1
2015
74
0.110
Why?
Cell Cycle
1
2016
511
0.110
Why?
Cisplatin
1
2016
599
0.110
Why?
Heptanoic Acids
2
2011
71
0.110
Why?
Longitudinal Studies
1
2017
1088
0.110
Why?
Molecular Targeted Therapy
1
2015
280
0.110
Why?
Cohort Studies
1
2020
2891
0.110
Why?
Nerve Tissue Proteins
1
2016
511
0.110
Why?
Pyrroles
2
2011
173
0.100
Why?
Apoptosis
2
2016
1725
0.100
Why?
Ezetimibe
1
2012
35
0.100
Why?
Risk Assessment
1
2020
2338
0.100
Why?
Drug Therapy, Combination
1
2014
795
0.100
Why?
Simvastatin
2
2016
106
0.100
Why?
Melanoma
1
2016
474
0.100
Why?
Cell Line
1
2016
2505
0.090
Why?
Smoking
1
2015
627
0.090
Why?
Global Health
1
2013
192
0.090
Why?
Cell Line, Tumor
1
2016
2609
0.080
Why?
Case-Control Studies
1
2014
1873
0.080
Why?
Age Factors
1
2014
1871
0.080
Why?
Transcription Factors
1
2016
1670
0.070
Why?
Carotid Artery, Common
1
2006
28
0.060
Why?
Aged
3
2018
19424
0.060
Why?
Carotid Artery, Internal
1
2006
69
0.060
Why?
Gadolinium DTPA
1
2006
256
0.060
Why?
Antineoplastic Agents
1
2016
2337
0.060
Why?
Double-Blind Method
3
2018
1727
0.060
Why?
Magnetic Resonance Imaging, Cine
1
2006
165
0.060
Why?
United States
1
2017
7142
0.060
Why?
Animals
3
2015
27715
0.050
Why?
Contrast Media
1
2006
1085
0.050
Why?
Predictive Value of Tests
2
2018
1747
0.040
Why?
Lipid Metabolism
2
2011
204
0.040
Why?
Colestipol
1
2016
3
0.030
Why?
Lovastatin
1
2016
29
0.030
Why?
Luciferases
1
2016
128
0.030
Why?
Hyperlipoproteinemias
1
2015
7
0.030
Why?
Chromatin Immunoprecipitation
1
2016
137
0.030
Why?
Proprotein Convertase 9
1
2015
20
0.030
Why?
Triglycerides
1
2016
235
0.030
Why?
Oligonucleotides, Antisense
1
2015
67
0.030
Why?
Fluorescent Antibody Technique
1
2016
324
0.030
Why?
Receptors, LDL
1
2015
55
0.030
Why?
Streptokinase
1
1995
12
0.030
Why?
Pulmonary Valve Insufficiency
1
1995
12
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
285
0.030
Why?
Serine Endopeptidases
1
2015
146
0.030
Why?
Transcriptional Activation
1
2016
295
0.030
Why?
Structure-Activity Relationship
1
2015
429
0.030
Why?
Blotting, Western
1
2016
795
0.030
Why?
RNA Interference
1
2015
377
0.030
Why?
Adipocytes
1
2015
167
0.030
Why?
Heart Valve Prosthesis
1
1995
100
0.030
Why?
Kaplan-Meier Estimate
1
2016
854
0.030
Why?
Protein Structure, Tertiary
1
2015
742
0.030
Why?
RNA, Small Interfering
1
2015
558
0.030
Why?
Peptide Fragments
1
2015
465
0.030
Why?
Binding Sites
1
2016
1127
0.030
Why?
Promoter Regions, Genetic
1
2016
961
0.030
Why?
Smoking Cessation
1
2015
264
0.020
Why?
Thrombolytic Therapy
1
1995
246
0.020
Why?
Idaho
1
2011
8
0.020
Why?
Apolipoproteins B
1
2011
36
0.020
Why?
Washington
1
2011
49
0.020
Why?
Epigenesis, Genetic
1
2015
526
0.020
Why?
Necrosis
1
2011
211
0.020
Why?
Prospective Studies
2
2011
4348
0.020
Why?
Cells, Cultured
1
2016
2895
0.020
Why?
Liver
1
2015
1218
0.020
Why?
Intestinal Mucosa
1
2015
807
0.020
Why?
Fibrosis
1
2011
238
0.020
Why?
RNA, Messenger
1
2016
2034
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2015
962
0.020
Why?
Antibodies, Monoclonal
1
2015
1397
0.020
Why?
Colesevelam Hydrochloride
1
2007
11
0.020
Why?
Allylamine
1
2007
11
0.020
Why?
Aged, 80 and over
1
2018
6816
0.020
Why?
Genetic Predisposition to Disease
1
2015
2364
0.020
Why?
Calcium
1
2011
1183
0.020
Why?
Signal Transduction
1
2016
3431
0.020
Why?
Brain
1
2015
2328
0.020
Why?
Postoperative Complications
1
1995
2342
0.010
Why?
Mutation
1
2015
4183
0.010
Why?
Mice
1
2015
11949
0.010
Why?
Reproducibility of Results
1
2006
2782
0.010
Why?
Prosthesis Design
1
1995
307
0.010
Why?
Phan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (167)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_